Cargando…
Premature drug reduction after subthalamic nucleus deep brain stimulation leading to worse depression in patients with Parkinson's disease
BACKGROUND: Reduction of medication in Parkinson's disease (PD) following subthalamic nucleus deep brain stimulation (STN-DBS) has been recognized, but the optimal timing for medication adjustments remains unclear, posing challenges in postoperative patient management. OBJECTIVE: This study aim...
Autores principales: | Diao, Yu, Hu, Tianqi, Xie, Hutao, Fan, Houyou, Meng, Fangang, Yang, Anchao, Bai, Yutong, Zhang, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620523/ https://www.ncbi.nlm.nih.gov/pubmed/37928164 http://dx.doi.org/10.3389/fneur.2023.1270746 |
Ejemplares similares
-
Effects of Subthalamic Nucleus Deep Brain Stimulation on Depression in Patients with Parkinson’s Disease
por: Hu, Tianqi, et al.
Publicado: (2022) -
A Meta-Analysis of the Effect of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson's Disease-Related Pain
por: Diao, Yu, et al.
Publicado: (2021) -
Profiling the low-beta characteristics of the subthalamic nucleus in early- and late-onset Parkinson’s disease
por: Wu, Delong, et al.
Publicado: (2023) -
Microstimulation Is a Promising Approach in Achieving Better Lead Placement in Subthalamic Nucleus Deep Brain Stimulation Surgery
por: Shi, Lin, et al.
Publicado: (2021) -
Optimal subthalamic stimulation sites and related networks for freezing of gait in Parkinson’s disease
por: Fan, Houyou, et al.
Publicado: (2023)